| Systematic (IUPAC) name | |
|---|---|
| 2-((2-(4-iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 10001761 |
| ChemSpider | 8177342 |
| Chemical data | |
| Formula | C17H20INO3 |
| Mol. mass | 413.249 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
25I-NBOH (NBOH-2CI, Cimbi-27) is a derivative of the phenethylamine derived hallucinogen 2C-I. It acts as a potent agonist for the 5HT2A receptor,[1][2] with a Ki of 0.12nM at the human 5HT2A receptor, making it some five times the potency of 2C-I itself. In vitro tests showed this compound acted as an agonist but animal studies have not been reported. While the N-benzyl derivatives of 2C-I were significantly increased in potency compared to 2C-I, the N-benzyl derivatives of DOI were inactive.[3]
It was discovered in 2006 by a team at Purdue University.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)